Exact Mass: 612.1008634
Exact Mass Matches: 612.1008634
Found 56 metabolites which its exact mass value is equals to given mass value 612.1008634,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Cefpiramide
Cefpiramide is only found in individuals that have used or taken this drug. It is a third-generation cephalosporin antibiotic. The bactericidal activity of cefpiramide results from the inhibition of cell wall synthesis via affinity for penicillin-binding proteins (PBPs). J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DD - Third-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
myricetin 3-O-beta-D-xylopyranosyl(1*2)-beta-D-glucopyranoside
4,4,5,5-tetrahydroxy-6,6,3-trimethoxy-[C7-O-C7]-biflavone
eriocauloside C|jaceosidin 7-O-beta-D-(6-O-p-hydroxybenzoyl)glucopyranoside
myricetin 3-O-β-D-xylopyranosyl(1-2)-β-D-glucopyranoside
Cefpiramide
A third-generation cephalosporin antibiotic with [(1-methyl-1H-tetrazol-5-yl)sulfanyl]methyl and (R)-2-{[(4-hydroxy-6-methylpyridin-3-yl)carbonyl]amino}-2-(4-hydroxyphenyl)acetamido groups at positions 3 and 7, respectively, of the cephem skeleton. It has a broad spectrum of antibacterial activity. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DD - Third-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
THEOPHYLLINE METHOXYOXIMERCURI-PROPYL SUCCINYLUREA
disodium 3,3-[carbonylbis[imino(3-methoxy-4,1-phenylene)azo]]dibenzoate
hydrogen 9-(2-carboxylatophenyl)-3-(2-methylanilino)-6-(2-methyl-4-sulphoanilino)xanthylium, monosodium salt
2-[4,5-bis(pentylsulfanyl)-1,3-dithiol-2-ylidene]-4,5-bis(pentylsulfanyl)-1,3-dithiole
1,12-Bis[4-methyl-5-(2-hydroxyethyl)thiazol-3-ium-3-yl]dodecane dibromide
C24H42Br2N2O2S2 (612.1054272000001)
6-Chloro-9-(2,3,5-tri-O-benzoyl-2-C-methyl-beta-D-ribofuranosyl)-9H-purine
Cefpirome sulfate
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic
sodium 2-[3-(4-sulfonato-o-tolyliminio)-6-o-toluidino-3H-xanthen-9-yl]benzoate
CMP-N-acetyl-beta-neuraminate(2-)
COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
6-[4-[3-[3,4-Dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-5,7-dihydroxy-4-oxo-2,3-dihydrochromen-2-yl]-2-hydroxyphenoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid
6-[(3-{[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-2-(3,4-dihydroxyphenyl)-7-hydroxy-4-oxo-3,4-dihydro-2H-1-benzopyran-5-yl)oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid
CMP-N-acetyl-beta-neuraminate(2-)
Dianion of CMP-N-acetyl-beta-neuraminate arising from deprotonation of carboxylic acid and phosphate functions; major species at pH 7.3.
3-{[4,5-dihydroxy-6-(hydroxymethyl)-3-[(3,4,5-trihydroxyoxan-2-yl)oxy]oxan-2-yl]oxy}-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one
(2s,3s,4s,5s,6s)-2-[2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxochromen-8-yl]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl 3,4-dimethoxybenzoate
3-{[(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}oxan-2-yl]oxy}-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one
2''-o-(3''',4'''-dimethoxybenzoyl)orientin
{"Ingredient_id": "HBIN006165","Ingredient_name": "2''-o-(3''',4'''-dimethoxybenzoyl)orientin","Alias": "NA","Ingredient_formula": "C30H28O14","Ingredient_Smile": "COC1=C(C=C(C=C1)C(=O)OC2C(C(C(OC2C3=C(C=C(C4=C3OC(=CC4=O)C5=CC(=C(C=C5)O)O)O)O)CO)O)O)OC","Ingredient_weight": "612.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6206","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "21578039","DrugBank_id": "NA"}
3-{[(2s,3r,4s,5s,6r)-3-{[(2s,3r,4r,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one
(2s)-2-[(1e)-2-(1,3-dihydroxy-5-methoxy-9-oxoxanthen-2-yl)ethenyl]-7,9-dihydroxy-12-methoxy-2-methyl-3h-1,4,5-trioxatetraphen-10-one
[(3r,4r)-3-amino-2,4-dihydroxy-3-(hydroxymethyl)-5-oxocyclopent-1-en-1-yl]oxy([(2r,3s,4r,5r)-4-hydroxy-5-(2-hydroxy-4-iminopyrimidin-1-yl)-3-{[(3r,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}oxolan-2-yl]methoxy)phosphinic acid
methyl (1s,17s,19s,27s)-27-(acetyloxy)-10,15,19,22-tetrahydroxy-24-methyl-13,18,20-trioxo-6-oxaheptacyclo[15.10.2.0¹,¹⁹.0³,¹⁶.0⁵,¹⁴.0⁷,¹².0²¹,²⁶]nonacosa-3(16),4,7,9,11,14,21,23,25,28-decaene-11-carboxylate
2-[(1e)-2-(1,3-dihydroxy-5-methoxy-9-oxoxanthen-2-yl)ethenyl]-7,9-dihydroxy-12-methoxy-2-methyl-3h-1,4,5-trioxatetraphen-10-one
2-[2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxochromen-8-yl]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl 3,4-dimethoxybenzoate
2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-{[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-{[(3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}chromen-4-one
3-{[(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-{[(2r,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}oxan-2-yl]oxy}-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one
2-[2-(1,3-dihydroxy-5-methoxy-9-oxoxanthen-2-yl)ethenyl]-7,9-dihydroxy-12-methoxy-2-methyl-3h-1,4,5-trioxatetraphen-10-one
methyl 27-(acetyloxy)-10,15,19,22-tetrahydroxy-24-methyl-13,18,20-trioxo-6-oxaheptacyclo[15.10.2.0¹,¹⁹.0³,¹⁶.0⁵,¹⁴.0⁷,¹².0²¹,²⁶]nonacosa-3(16),4,7,9,11,14,21,23,25,28-decaene-11-carboxylate
(2s,3r,4r,5r,6r)-2,3,4-trihydroperoxy-6-(hydroxymethyl)-6-phenoxy-5-(phenylperoxy)-2-(3,4,5-trihydroxybenzoyl)oxane-3,4,5-triol
3-[(3-{[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl)oxy]-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chromen-4-one
3,5,7-trihydroxy-2-(4-methoxyphenyl)-8-{[3,5,7-trihydroxy-2-(4-methoxyphenyl)-4-oxochromen-8-yl]methyl}chromen-4-one
(1r,3s,9s,23s,32r)-23,32-dihydroxy-15,19-dimethoxy-28-methyl-6,10,17-trioxa-25,26-dithia-2,28-diazaheptacyclo[22.2.2.1¹,⁴.1²,²⁴.1¹²,¹⁶.1¹⁸,²².0³,⁹]dotriaconta-4,7,12,14,16(31),18(30),19,21-octaene-11,27,29-trione
C28H24N2O10S2 (612.0872324000001)
5-hydroxy-7-{[5-hydroxy-2-(4-hydroxyphenyl)-6-methoxy-4-oxochromen-7-yl]oxy}-2-(4-hydroxy-3-methoxyphenyl)-6-methoxychromen-4-one
9-hydroxy-7,12-dimethoxy-2-methyl-2-[(1e)-2-(1,3,5-trihydroxy-9-oxoxanthen-2-yl)ethenyl]-3h-1,4,5-trioxatetraphen-10-one
(6-{[2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-2,3-dihydro-1-benzopyran-3-yl]oxy}-3,4,5-trihydroxyoxan-2-yl)methyl 3-(4-hydroxyphenyl)prop-2-enoate
(2r,3r,4r,5r,6r)-2,3,4-trihydroperoxy-6-(hydroxymethyl)-6-phenoxy-5-(phenylperoxy)-2-(3,4,5-trihydroxybenzoyl)oxane-3,4,5-triol
[(2r,3s,4s,5r,6s)-6-{[(2s,3r)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-2,3-dihydro-1-benzopyran-3-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methyl (2e)-3-(4-hydroxyphenyl)prop-2-enoate
23,32-dihydroxy-15,19-dimethoxy-28-methyl-6,10,17-trioxa-25,26-dithia-2,28-diazaheptacyclo[22.2.2.1¹,⁴.1²,²⁴.1¹²,¹⁶.1¹⁸,²².0³,⁹]dotriaconta-4,7,12,14,16(31),18(30),19,21-octaene-11,27,29-trione
C28H24N2O10S2 (612.0872324000001)